Log In
BCIQ
Print this Print this
 

nimorazole (Nimoral)

  Manage Alerts
Collapse Summary General Information
Company Azanta A/S
DescriptionGranule formulation of nitroimidazole
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationHead and neck cancer
Indication DetailsTreat squamous cell carcinoma of the head and neck in patients undergoing radiotherapy
Regulatory Designation EU - Orphan Drug (Treat squamous cell carcinoma of the head and neck in patients undergoing radiotherapy)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today